Fujifilm starts a Phase I clinical trial in the United States for the anti-cancer agent FF-10502 targeting solid tumors including pancreatic cancer
18.02.2016
FUJIFILM Corporation (President: Shigehiro Nakajima) has begun a Phase I clinical trial of its anti-cancer agent FF-10502 in the United States on patients with solid tumors, including pancreatic cancer. The trial will be expanded in facilities including at the University of Texas MD Anderson Cancer Center*, one of the worlds most distinguished facilities for cancer research and treatment.
Pancreatic cancer is one of the difficult gastrointestinal cancers to treat, with limited choices of drugs and poor prognosis. The number of the patients developing pancreatic cancer is estimated to be approximately 50,000 and 35,000 per year in the United States and in Japan, respectively.
FF-10502 possesses anti-cancer effects by inhibiting DNA synthesis of the cancer cells. The effectiveness of FF-10502 includes regression of tumor tissues superior to a currently available drug, in pre-clinical mouse models of pancreatic cancer without significant difference in the safety profile from the existing drug. It has also shown potent anti-cancer effects in growth inhibition of cancer cells derived from patients with lung, ovarian and bladder cancers. FF-10502 required a long process in its chemical synthesis due to the unique structure, which resulted in difficulty in the development. Fujifilm has applied its advanced technologies in the chemical design and synthesis to improve the process and achieved lower costs.
MD Anderson Cancer Center is one of the worlds top general cancer centers with over 10,000 patients on therapeutic clinical trials each year, and some 20,000 employees. Fujifilm is utilizing the worlds top-level clinical testing functions available at the MD Anderson Cancer Center to speedily and seamlessly carry out Phase I clinical trials of FF-10502, to gain its safety profile and efficacies, and facilitates the development for early approval.
Fujifilm is defining oncology as its focal area and promoting the R&D of new drugs. Fujifilm has initiated clinical trials of anti-cancer agents FF-10501 for the treatment of relapsed or refractory blood tumors since August 2014, and FF-21101 for solid tumors such as lung cancer since January 2016 also at MD Anderson Cancer Center. The emerging results have revealed that to date FF-10501 has been well tolerated in those patients and produced positive responses in some patients. These results were presented last December at the 57th American Society of Hematology Meeting (Orlando, Florida), the biggest hematology meeting in the US.
Fujifilm is working on the R&D of innovative pharmaceutical products and creation of their production processes by combining the technologies and knowledge accumulated in the photographic film business including analysis technology, chemical design and synthesis technology, nanotechnology, and production technology, with the technological expertise of its core pharmaceutical affiliates such as Toyama Chemical Co., Ltd. Defining oncology, a field with numerous unmet medical needs as its focus, the company will actively promote R&D to expand business deployment and supply innovative pharmaceutical products to contribute to resolving challenging social and health issues.
*One of the worlds largest cancer centers based in Houston, Texas (USA), specializing in cancer treatment, research, education and prevention. It was established in 1941 with a mission to eliminate cancer. Under the core values of Caring, Integrity, and Discovery, the center has developed numerous new cancer treatments as an international leader in oncology.
For enquiries on information in this media release, contact:
Media Contact:FUJIFILM Corporation
Corporate Communications Division
TEL: +81 3-6271-2000
Other:Pharmaceutical Products Division
TEL: +81 3-6271-2171
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
30/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
30/05/2026
Zero in on one that says yes (and no)
Andy Marken May 29, 2026
0 Comments
Hero image courtesy of Deposit Photos
For content creators the most difficu...
29/05/2026
With InfoComm 2026 just weeks away, NDI is giving attendees plenty of reasons to...
29/05/2026
Reaffirming a partnership that has defined Canadian sports broadcasting since 19...
29/05/2026
Mobile/tablet is No. 2 device for watching TV, suggesting that the sports-production industry needs to take another look at the format
Ring Digital's Sprin...
29/05/2026
Berliner Ensemble, one of Berlin's five major theater companies, has expande...
29/05/2026
Solid State Logic will showcase its new compact, fly-away TCA Tour audio product...
29/05/2026
Gerald (Jerry) Pierce, a pioneering technologist who helped shape the digital transformation of the motion picture industry, passed away last month on April 12 ...
29/05/2026
Paramount+ will be the English-language U.S. home for Barclays Women's Super...
29/05/2026
Further strengthening its virtualisation strategy to fully support broadcasters ...
29/05/2026
Swiss broadcaster Canal Alpha has deployed Harmonic's award-winning, software-based XOS Advanced Media Processor to modernize playout operations across cant...
29/05/2026
PTZOptics will showcase a new generation of intelligent video workflows at InfoComm 2026, June 17-19, Las Vegas. Visitors to booth N8227 will see how PTZOptics ...
29/05/2026
Arizona's Family has launched the Arizona's Family Sports (AZFS) streaming app, a new direct-to-consumer destination for live, local sports. The app is ...
29/05/2026
Starting in 2027, DAZN will be the exclusive home of The Canadian Football Leagu...
29/05/2026
Comcast Business has detailed the advanced network infrastructure it has deploye...
29/05/2026
In two-day event, leaders from academia and industry explored solutions to chall...
29/05/2026
The Basketball Tournament (TBT), now entering their 13th year of competition, ha...
29/05/2026
Roku has launched FOX One as a Premium Subscription on The Roku Channel in the U.S. Roku customers can now subscribe to FOX One using their Roku account for liv...
29/05/2026
In its sixth year, the broadcaster's coverage has become a global brand and ...
29/05/2026
Ratings Roundup is a rundown of recent ratings news and is derived from press re...
29/05/2026
The days are getting longer, the temperatures are rising, and playlists are filling up for the season. With summer around the corner, Spotify's global edito...
29/05/2026
New retro-inspired MPC announced
There are few devices that have gained the status held by Akai Pro's MPC range, and in recent years, the company have s...
29/05/2026
Save up to 30 on acclaimed titles
Following a successful launch at Superbooth 2026, Bjooks have revealed that they will be continuing the Kickstarter campa...
29/05/2026
Binaural monitoring application improved
Genelec have just released an update that brings some powerful new features to their HRTF-based binaural headphone ...
29/05/2026
6 June 2026 at SAE Institute, London, UK
IMSTA FESTA 2026 is almost upon us, with some of the biggest names in pro-audio set to descend upon SAE Institute i...
29/05/2026
Gerald (Jerry) Pierce, a pioneering technologist who helped shape the digital transformation of the motion picture industry, died April 12, 2026, at his home in...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Comparing 5 AI Video Enhancers for Restoring Old Video Quality
Kate Luvis May 29, 2026
0 Comments
Digitizing VHS, MiniDV, and other legacy formats doe...
29/05/2026
Studio Hamburg Builds New Post Pipeline with DaVinci Resolve Studio
Brie Clayton May 29, 2026
0 Comments
Workflow replaces a patchwork of legacy tools...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
29/05/2026
At the Intersection of Music and Dance, an Epic Collaboration Boston Conservatory musicians and dancers found creative parallels in their recent performance o...
29/05/2026
May 29 2026, 09:00 (PDT) Dolby and rednote Bring More Immersive Storytelling to...
29/05/2026
Something fundamental has shifted in how people consume media. Audiences aren't abandoning television or radio content; they're just expanding how, wher...
29/05/2026
Youtube exclusive special drops today
Watch now
UKTV today announces another e...
29/05/2026
Back to All News
The Official Trailer of Physical 100 Italy, on Netflix From Se...
29/05/2026
At just 20 years old, Sean Melia from Summerhill Co. Meath has been revealed as the winner of Super Garden 2026. Sean is the youngest ever contestant and winner...
29/05/2026
Experimental HIV vaccine achieves a long-sought goal In a first for the field, all non-human primates given a new series of vaccines generated antibodies capabl...
Fujifilm starts a Phase I clinical trial in the United States for the anti-cancer agent FF-10502 targeting solid tumors including pancreatic cancer 
